Aspirin for thromboembolic prophylaxis emerging from the uncertain world of observational evidence

Written By Krista Verlis

Harris IA, Sidhu VS, MacDessi SJ, Solomon M, Haddad FS.

Aspirin for thromboembolic prophylaxis. Bone Joint J. 2024;106-B(7):642-645. doi:10.1302/0301-620X.106B7.BJJ-2024-0621

Krista Verlis
Previous

Randomized Noninferiority Trial to Compare Enteral to Parenteral Phosphate Replacement on Biochemistry, Waste, Enviro Impact & Healthcare Cost in Critically Ill Patients With Hypophosphatemia*
Next

Prioritisation of clinical trial learning needs of musculoskeletal researchers: an inter-disciplinary modified Delphi study by the Australia & New Zealand musculoskeletal clinical trials network